Christopher Liu
Stock Analyst at Leerink Partners
(1.74)
# 1390
Out of 5,243 analysts
5
Total ratings
50.00%
Success rate
36.37%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Relay Therapeutics | Maintains: Outperform | 19 18 | 4 | 350% | 1 | Dec 4, 2024 | |
IDEAYA Biosciences | Downgrades: Market Perform | 41 27 | 23.32 | 15.78% | 2 | Nov 5, 2024 | |
Nuvalent | Initiates Coverage On: Market Perform | 42 | 75.22 | -44.16% | 1 | Aug 8, 2023 | |
Exelixis | Initiates Coverage On: Market Perform | 18 | 36.83 | -51.13% | 1 | Aug 8, 2023 |